Literature DB >> 28093453

Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer.

Johan Gagnière1,2,3, Virginie Bonnin1,2, Anne-Sophie Jarrousse4, Emilie Cardamone1,2, Allison Agus1,2,5, Nancy Uhrhammer5, Pierre Sauvanet1,2,3, Pierre Déchelotte4, Nicolas Barnich1,2, Richard Bonnet1,2,6, Denis Pezet1,2,3, Mathilde Bonnet7,2.   

Abstract

Recent studies suggest that colonization of colonic mucosa by pathogenic Escherichia coli could be involved in the development of colorectal cancer (CRC), especially through the production of genotoxins such as colibactin and/or by interfering with the DNA mismatch repair (MMR) pathway that leads to microsatellite instability (MSI). The present study, performed on 88 CRC patients, revealed a significant increase in E. coli colonization in the MSI CRC phenotype. In the same way, E. coli persistence and internalization were increased in vitro in MMR-deficient cells. Moreover, we demonstrated that colibactin-producing E. coli induce inhibition of the mutL homologue 1 (MLH1) MMR proteins, which could lead to genomic instability. However, colibactin-producing E. coli were more frequently identified in microsatellite stable (MSS) CRC. The present study suggests differences in the involvement of colibactin-producing E. coli in colorectal carcinogenesis according to the CRC phenotype. Further host-pathogen interactions studies should take into account CRC phenotypes.
© 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Escherichia coli; colibactin; colorectal cancer; microsatellite instability; mutL homologue 1 (MLH1); oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28093453     DOI: 10.1042/CS20160876

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

Review 1.  Microbiota, Inflammation and Colorectal Cancer.

Authors:  Cécily Lucas; Nicolas Barnich; Hang Thi Thu Nguyen
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

2.  The Dynamic Changes of Gut Microbiota in Muc2 Deficient Mice.

Authors:  Minna Wu; Yaqi Wu; Jianmin Li; Yonghua Bao; Yongchen Guo; Wancai Yang
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

3.  E. coli diversity: low in colorectal cancer.

Authors:  Le Tang; Yu-Jie Zhou; Songling Zhu; Gong-Da Liang; He Zhuang; Man-Fei Zhao; Xiao-Yun Chang; Hai-Ning Li; Zheng Liu; Zhi-Rong Guo; Wei-Qiao Liu; Xiaoyan He; Chun-Xiao Wang; Dan-Dan Zhao; Jia-Jing Li; Xiao-Qin Mu; Bing-Qing Yao; Xia Li; Yong-Guo Li; Li-Bo Duo; Li Wang; Randal N Johnston; Jin Zhou; Jing-Bo Zhao; Gui-Rong Liu; Shu-Lin Liu
Journal:  BMC Med Genomics       Date:  2020-04-06       Impact factor: 3.063

4.  Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE).

Authors:  Johan Gagniere; Mathilde Bonnet; Julie Veziant; Karine Poirot; Caroline Chevarin; Lucie Cassagnes; Pierre Sauvanet; Benoit Chassaing; Frederic Robin; Catherine Godfraind; Nicolas Barnich; Denis Pezet; Bruno Pereira
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692

5.  Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort.

Authors:  Julia Butt; Mazda Jenab; Jill Werner; Veronika Fedirko; Elisabete Weiderpass; Christina C Dahm; Anne Tjønneland; Anja Olsen; Marie-Christine Boutron-Ruault; Joseph A Rothwell; Gianluca Severi; Rudolf Kaaks; Renée Turzanski-Fortner; Krasimira Aleksandrova; Matthias Schulze; Domenico Palli; Valeria Pala; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Bas Bueno-de-Mesquita; Carla H Van Gils; Inger Torhild Gram; Marko Lukic; Núria Sala; María José Sánchez Pérez; Eva Ardanaz; María-Dolores Chirlaque; Richard Palmquist; Thyra Löwenmark; Ruth C Travis; Alicia Heath; Amanda J Cross; Heinz Freisling; Semi Zouiouich; Elom Aglago; Tim Waterboer; David J Hughes
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 6.  The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Authors:  Jiayao Ma; Lingjuan Huang; Die Hu; Shan Zeng; Ying Han; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16

Review 7.  Microbiota medicine: towards clinical revolution.

Authors:  Prisca Gebrayel; Carole Nicco; Souhaila Al Khodor; Jaroslaw Bilinski; Elisabetta Caselli; Elena M Comelli; Markus Egert; Cristina Giaroni; Tomasz M Karpinski; Igor Loniewski; Agata Mulak; Julie Reygner; Paulina Samczuk; Matteo Serino; Mariusz Sikora; Annalisa Terranegra; Marcin Ufnal; Romain Villeger; Chantal Pichon; Peter Konturek; Marvin Edeas
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 8.  Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer.

Authors:  Julie Veziant; Romain Villéger; Nicolas Barnich; Mathilde Bonnet
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

Review 9.  Colibactin: More Than a New Bacterial Toxin.

Authors:  Tiphanie Faïs; Julien Delmas; Nicolas Barnich; Richard Bonnet; Guillaume Dalmasso
Journal:  Toxins (Basel)       Date:  2018-04-10       Impact factor: 4.546

Review 10.  Microbial markers in colorectal cancer detection and/or prognosis.

Authors:  Romain Villéger; Amélie Lopès; Julie Veziant; Johan Gagnière; Nicolas Barnich; Elisabeth Billard; Delphine Boucher; Mathilde Bonnet
Journal:  World J Gastroenterol       Date:  2018-06-14       Impact factor: 5.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.